SENORES.NS Earnings — Senores Pharmaceuticals Ltd.

NSE

Updated Oct 30, 2026

Price —

Market Cap $52.2B

P/E 43.8

52W Range — – —

When is SENORES.NS's next earnings date?

Senores Pharmaceuticals Ltd. (SENORES.NS) has not announced its next earnings date yet. Its most recent earnings report was on Friday, October 30, 2026.

How did SENORES.NS do in its last earnings report?

In its most recent report on Oct 30, 2026, Senores Pharmaceuticals Ltd. posted EPS of $0.09 versus the $8.25 estimate, a miss of 99.0%. Revenue was $21.6M against a $2.07B estimate.

How much does SENORES.NS stock move after earnings?

SENORES.NS beat EPS estimates in 1 of its last 2 reported quarters.

About Senores Pharmaceuticals Ltd.

Established in 2017 and headquartered in Ahmedabad, India, Senores Pharmaceuticals Ltd. is actively involved in the development, manufacturing, and global commercialization of pharmaceutical and related products. Its extensive portfolio reaches markets across India, the United States, the United Kingdom, Canada, and other international territories. The company specializes in a diverse array of therapeutic solutions, encompassing analgesics/antipyretics, anesthetics, antibacterials, antivirals, antifungals, antioxidants, antineoplastics, blood-related therapies, cardiovascular and neurological medications, antacids, and vitamin and mineral supplements. Additionally, Senores offers a selection of generic drugs targeting pain, inflammation, fever, diabetes, malaria, and urinary tract conditions, as well as neutral supplements. Complementing its product offerings, the firm also provides management and consultancy services.